Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.
Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 16, 2021 | Series C | $66M | 1 | — | — | Detail |
Apr 25, 2017 | Series A | $2M | 1 | — | — | Detail |
Dec 21, 2016 | Series A | $4.50M | 1 | — | — | Detail |
Sep 22, 2014 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hartford HealthCare Endowment | — | Series C |
Whitesun Healthcare Ventures | — | Series A |
Pfizer | — | Series A |